Evidence map›Paper›PMID 29176754›Full record

ArticleScientific reports2017

The O-specific polysaccharide lyase from the phage LKA1 tailspike reduces Pseudomonas virulence.

Tomasz Olszak, Mikhail M Shneider, Agnieszka Latka, Barbara Maciejewska, Christopher Browning, Lada V Sycheva, Anneleen Cornelissen, Katarzyna Danis-Wlodarczyk, Sofya N Senchenkova, Alexander S Shashkov and 8 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Prophage: agent provocateur?Archives of microbiology · 2026
    Review
  3. Phage-Based Approaches to ChronicAntibiotics (Basel, Switzerland) · 2026
    Review
  4. Phage and endolysin-based inhibition ofFrontiers in cellular and infection microbiology · 2026
    Review
  5. Understanding phage Receptor-binding protein interaction with host surface receptor: the key for phage-Mediated detection and elimination of Pseudomonas aeruginosa.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  6. Antivirulence Activity and Therapeutic Potential of JumboJournal of microbiology and biotechnology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. The Ability of Bacteriophages to Reduce Biofilms Produced byAntibiotics (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Enterococcal quorum-controlled protease alters phage infection.bioRxiv : the preprint server for biology · 2024
    Article
  18. mBio · 2024
    Article
  19. Acta pharmaceutica Sinica. B · 2024
    Review
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 5 countries.

Tomasz OlszakInstitute of Genetics and Microbiology, University of Wroclaw, Wroclaw, 51-148, Poland.
Mikhail M ShneiderShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia.
Agnieszka LatkaInstitute of Genetics and Microbiology, University of Wroclaw, Wroclaw, 51-148, Poland.
Barbara MaciejewskaInstitute of Genetics and Microbiology, University of Wroclaw, Wroclaw, 51-148, Poland.
Christopher BrowningVertex Pharmaceuticals (Europe) Ltd, Abingdon, Oxfordshire, OX14 4RW, UK.
Lada V SychevaAffinivax Inc., Cambridge, 02139-3543, Massachusetts, USA.
Anneleen CornelissenLaboratory of Gene Technology, KU Leuven, Leuven, 3001, Belgium.
Katarzyna Danis-WlodarczykInstitute of Genetics and Microbiology, University of Wroclaw, Wroclaw, 51-148, Poland.
Sofya N SenchenkovaN. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, 119991, Russia.
Alexander S ShashkovN. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, 119991, Russia.
Grzegorz GulaInstitute of Genetics and Microbiology, University of Wroclaw, Wroclaw, 51-148, Poland.
Michal ArabskiDepartment of Biochemistry and Genetics, Institute of Biology, The Jan Kochanowski University in Kielce, Kielce, 25-406, Poland.
Slawomir WasikDepartment of Molecular Physics, Institute of Physics, The Jan Kochanowski University in Kielce, Kielce, 25-406, Poland.
Konstantin A MiroshnikovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia.
Rob LavigneLaboratory of Gene Technology, KU Leuven, Leuven, 3001, Belgium.
Petr G LeimanUniversity of Texas Medical Branch, Department of Biochemistry and Molecular Biology, Sealy Center for Structural Biology and Molecular Biophysics, Galveston, TX, 77555-0647, USA.ORCID 0000-0002-9091-0918
Yuriy A KnirelN. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, 119991, Russia.
Zuzanna Drulis-KawaInstitute of Genetics and Microbiology, University of Wroclaw, Wroclaw, 51-148, Poland. zuzanna.drulis-kawa@uwr.edu.pl.
University of Wrocław · PLN.D. Zelinsky Institute of Organic Chemistry · RUInstitute of Bioorganic Chemistry · RUJan Kochanowski University · PLKU Leuven · BEThe University of Texas Medical Branch at Galveston · USVertex Pharmaceuticals (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomonas phage LKA1 of the subfamily Autographivirinae encodes a tailspike protein (LKA1gp49) which binds and cleaves B-band LPS (O-specific antigen, OSA) of Pseudomonas aeruginosa PAO1. The crystal structure of LKA1gp49 catalytic domain consists of a beta-helix, an insertion domain and a C-terminal discoidin-like domain. The putative substrate binding and processing site is located on the face of the beta-helix whereas the C-terminal domain is likely involved in carbohydrates binding. NMR spectroscopy and mass spectrometry analyses of degraded LPS (OSA) fragments show an O5 serotype-specific polysaccharide lyase specificity. LKA1gp49 reduces virulence in an in vivo Galleria mellonella infection model and sensitizes P. aeruginosa to serum complement activity. This enzyme causes biofilm degradation and does not affect the activity of ciprofloxacin and gentamicin. This is the first comprehensive report on LPS-degrading lyase derived from a Pseudomonas phage. Biological properties reveal a potential towards its applications in antimicrobial design and as a microbiological or biotechnological tool.

Indexed as

BacteriophagesBiofilmsO AntigensPolysaccharide-LyasesPseudomonasVirulenceO AntigensPolysaccharide-Lyases

Identifiers

PMID29176754
PMCPMC5701251
OpenAlexW2768649360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.